Rashmi J. Rao

Sep 20, 2024 | biorxiv.org | Rashmi J. Rao |Jimin Yang |Siyi Jiang |Wadih El Khoury

AbstractPulmonary arterial hypertension (PAH) is a progressive disease driven by endothelial cell inflammation and dysfunction, resulting in the pathological remodeling of the pulmonary vasculature. Innate immune activation has been linked to PAH development; however, the regulation, propagation, and reversibility of the induction of inflammation in PAH is poorly understood.

Apr 22, 2024 | ahajournals.org | Stephen Chan |Rashmi J. Rao

REFERENCES1. Sakao S, Tatsumi K, Voelkel NF. Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and transdifferentiation.Respir Res. 2009; 10:95. doi: 10.1186/1465-9921-10-95CrossrefMedlineGoogle Scholar2. Frump AL, Lahm T. The basic science of metabolism in pulmonary arterial hypertension.Adv Pulm Hypertens. 2018; 17:95–102. doi: 10.21693/1933-088x-17.3.95CrossrefGoogle Scholar3. Luo Y, Qi X, Zhang Z, Zhang J, Li B, Shu T, Li X, Hu H, Li J, Tang Q, .